Cataplexy And Excessive Daytime Sleepiness In Narcolepsy Therapeutics
1. Xyrem patent expiration
Treatment: Method of treating cataplexy in patients with narcolepsy; Method of treating a patient with a prescription drug using a computer database in a computer system for distribution; Method of treating exce...
XYREM's oppositions filed in EPO
XYREM IPR and PTAB Proceedings
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US9539330 (Pediatric) | JAZZ | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
Jun, 2020
(5 years ago) | |
| US8952062 | JAZZ | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
Dec, 2019
(6 years ago) | |
| US8589182 | JAZZ | Sensitive drug distribution system and method |
Dec, 2022
(3 years ago) | |
| US8731963 | JAZZ | Sensitive drug distribution system and method |
Dec, 2022
(3 years ago) | |
|
US8731963 (Pediatric) | JAZZ | Sensitive drug distribution system and method |
Jun, 2023
(2 years ago) | |
| US8263650 | JAZZ | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
Dec, 2019
(6 years ago) | |
|
US6780889 (Pediatric) | JAZZ | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
Jan, 2021
(5 years ago) | |
|
US7262219 (Pediatric) | JAZZ | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
Jan, 2021
(5 years ago) | |
|
US7765107 (Pediatric) | JAZZ | Sensitive drug distribution system and method |
Dec, 2024
(1 year, 2 months ago) | |
|
US7895059 (Pediatric) | JAZZ | Sensitive drug distribution system and method |
Jun, 2023
(2 years ago) | |
|
US8457988 (Pediatric) | JAZZ | Sensitive drug distribution system and method |
Jun, 2023
(2 years ago) | |
| US7262219 | JAZZ | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
Jul, 2020
(5 years ago) | |
|
US7765106 (Pediatric) | JAZZ | Sensitive drug distribution system and method |
Dec, 2024
(1 year, 2 months ago) | |
| US8859619 | JAZZ | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
Dec, 2019
(6 years ago) | |
|
US8589182 (Pediatric) | JAZZ | Sensitive drug distribution system and method |
Jun, 2023
(2 years ago) | |
|
US7851506 (Pediatric) | JAZZ | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
Jun, 2020
(5 years ago) | |
|
US8263650 (Pediatric) | JAZZ | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
Jun, 2020
(5 years ago) | |
|
US8324275 (Pediatric) | JAZZ | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
Jun, 2020
(5 years ago) | |
|
US8859619 (Pediatric) | JAZZ | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
Jun, 2020
(5 years ago) | |
|
US8952062 (Pediatric) | JAZZ | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
Jun, 2020
(5 years ago) | |
| US9539330 | JAZZ | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
Dec, 2019
(6 years ago) | |
| US8457988 | JAZZ | Sensitive drug distribution system and method |
Dec, 2022
(3 years ago) | |
| US8324275 | JAZZ | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
Dec, 2019
(6 years ago) | |
| US7668730 | JAZZ | Sensitive drug distribution system and method |
Jun, 2024
(1 year, 8 months ago) | |
|
US7668730 (Pediatric) | JAZZ | Sensitive drug distribution system and method |
Dec, 2024
(1 year, 2 months ago) | |
| US7895059 | JAZZ | Sensitive drug distribution system and method |
Dec, 2022
(3 years ago) | |
| US7851506 | JAZZ | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
Dec, 2019
(6 years ago) | |
| US7765107 | JAZZ | Sensitive drug distribution system and method |
Jun, 2024
(1 year, 8 months ago) | |
| US7765106 | JAZZ | Sensitive drug distribution system and method |
Jun, 2024
(1 year, 8 months ago) | |
| US6780889 | JAZZ | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
Jul, 2020
(5 years ago) | |
| US9486426 | JAZZ | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Mar, 2033
(7 years from now) | |
| US9050302 | JAZZ | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Mar, 2033
(7 years from now) | |
| US8772306 | JAZZ | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Mar, 2033
(7 years from now) | |
| US11986446 | JAZZ | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Mar, 2033
(7 years from now) | |
| US10213400 | JAZZ | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Mar, 2033
(7 years from now) | |
| US11253494 | JAZZ | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Mar, 2033
(7 years from now) | |
| US10864181 | JAZZ | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Mar, 2033
(7 years from now) | |
|
US8772306 (Pediatric) | JAZZ | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Sep, 2033
(7 years from now) | |
|
US9486426 (Pediatric) | JAZZ | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Sep, 2033
(7 years from now) | |
|
US9050302 (Pediatric) | JAZZ | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Sep, 2033
(7 years from now) | |
|
US11253494 (Pediatric) | JAZZ | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Sep, 2033
(7 years from now) | |
|
US10213400 (Pediatric) | JAZZ | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Sep, 2033
(7 years from now) | |
|
US10864181 (Pediatric) | JAZZ | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Sep, 2033
(7 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE) | Nov 18, 2012 |
| New Patient Population(NPP) | Oct 26, 2021 |
| Orphan Drug Exclusivity(ODE-231) | Oct 26, 2025 |
| Pediatric Exclusivity(PED) | Apr 26, 2026 |
Drugs and Companies using SODIUM OXYBATE ingredient
Market Authorisation Date: 17 July, 2002
Dosage: SOLUTION
How can I launch a generic of XYREM before it's drug patent expiration?
More Information on Dosage
XYREM family patents
